Status:
UNKNOWN
Respiratory Microbiome in COPD and Associated Inmune Response.
Lead Sponsor:
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Conditions:
Pulmonary Disease (COPD), Chronic Obstructive
Eligibility:
All Genders
40-80 years
Brief Summary
Hypothesis: COPD patients with frequent exacerbations have different pulmonary and systemic immune response than COPD patients without frequent exacerbations and this is related to their microbiome.
Detailed Description
The objective of this project is to determine the pulmonary microbiome and its relationship with the pulmonary and systemic inmune response in COPD patients with frequent (FE) and non frequent exacerb...
Eligibility Criteria
Inclusion
- Diagnosis of COPD according to national and international guidelines.
- Clinical stability (8 previous weeks).
- Signature of informed consent.
Exclusion
- Antibiotic treatment the previous 8 weeks.
- Other lung diseases.
- Active neoplasic disease.
- Terminal concomitant disease.
Key Trial Info
Start Date :
March 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2018
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03321708
Start Date
March 1 2016
End Date
December 1 2018
Last Update
October 26 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oriol Sibila Vidal
Barcelona, Spain, 08041